Ajanta Pharma informs about disclosure

14 Sep 2021 Evaluate
Ajanta Pharma has informed that the exchange has received disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on September 14,2021 for Ravi Agrawal, Trustee Ravi Agrawal Trust.

The above information is a part of company’s filings submitted to BSE.

Ajanta Pharma Share Price

2720.00 23.60 (0.88%)
28-Jan-2026 15:07 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1612.35
Dr. Reddys Lab 1225.15
Cipla 1325.75
Zydus Lifesciences 895.95
Lupin 2132.50
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×